Stories
Zydus Life Secures Final US FDA Approval for Transdermal System
M
Moneycontrol•21-10-2026, 12:40
Zydus Life Secures Final US FDA Approval for Transdermal System
- •Zydus Life has received final approval from the US FDA for the Estradiol and Levonorgestrel Transdermal System.
- •The announcement was featured in Moneycontrol's live business news updates.
Key Questions Answered
Zydus Life received final approval from the US Food and Drug Administration (US FDA) for the Estradiol and Levonorgestrel Transdermal System.
Zydus Lifesciences received approval from China's National Medical Products Administration (NMPA) for its Desidustat tablets used to treat renal anaemia in chronic kidney disease patients.
Zydus Therapeutics received priority review designation from the US FDA for the New Drug Application of saroglitazar for treating primary biliary cholangitis.
